Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • NEUROCRINE BIOSCIENCES INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 80.47 M 179.38 M 182.60 M 273.07 M 301.13 M
    Net Receivables 39,000.00 27,000.00 7.19 M 858,000.00 8.21 M
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 911,000.00 3.54 M 3.86 M 5.38 M 4.47 M
    Current Assets Total 81.42 M 182.95 M 193.66 M 279.31 M 313.82 M
    Long Term Receivables 0.00 0.00 315,000.00 483,000.00 69,000.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 30.57 M 11.10 M 10.33 M 9.98 M 8.65 M
    Property, Plant & Equipment Net 6.19 M 82.60 M 91.38 M 99.31 M 102.17 M
    Property, Plant & Equipment Gross 45.16 M 128.68 M 128.86 M 126.68 M 120.68 M
    Accumulated Depreciation 38.96 M 46.08 M 37.48 M 27.37 M 18.51 M
    Other Assets 2,000.00 9,000.00 94.00 M 94.05 M 94.59 M
    Deferred Charges 94.00 M 94.00 M 94.00 M — —
    Tangible Other Assets 2,000.00 9,000.00 0.00 48,000.00 586,000.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 118.18 M 276.65 M 389.68 M 483.12 M 519.29 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 1.49 M 4.49 M 5.81 M 6.67 M
    Accrued Payroll 4.46 M 4.11 M 5.39 M 6.36 M 5.20 M
    Income Taxes Payable — — — — —
    Dividends Payable — — — — —
    Other Current Liabilities 20.04 M 20.53 M 7.02 M 18.07 M 42.32 M
    Current Liabilities Total 26.09 M 29.91 M 20.12 M 33.69 M 59.58 M
    Long Term Debt 0.00 108.74 M 49.15 M 53.59 M 59.45 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 44.54 M 14.60 M 0.00 0.00 2.00 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 10.77 M 4.71 M 5.69 M 5.74 M 4.35 M
    Total Liabilities 81.41 M 157.96 M 74.96 M 93.02 M 125.39 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 36.77 M 118.70 M 314.72 M 390.10 M 393.90 M
    Common Stock 39,000.00 38,000.00 38,000.00 37,000.00 37,000.00
    Capital Surplus 741.57 M 733.54 M 721.93 M 691.72 M 674.03 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves — — — — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -703.26 M -614.65 M -407.35 M -300.15 M -277.96 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 312,000.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -1.57 M -233,000.00 99,000.00 -1.50 M -1.91 M
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 118.18 M 276.65 M 389.68 M 483.12 M 519.29 M
    Common Shares Outstanding 38.60 M 38.27 M 37.91 M 37.13 M 36.53 M